Coagulation Analyzers Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 8.85 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Coagulation Analyzers Market Analysis
The coagulation analyzers market is expected to grow at a CAGR of around 8.85% over the forecast period, 2022-2027.
The COVID-19 pandemic has affected the economics and sectors of many different countries due to lockdowns, travel restrictions, and business closures. The outbreak of COVID-19 causes the global shutdown which compelled the manufacturers of coagulation analyzers to halt manufacturing and distribution. The COVID-19 pandemic had a huge impact on the coagulation analyzer market. According to a November 2021 study titled "Meta-analysis of coagulation parameters connected with sickness severity and bad prognosis of COVID-19," coagulation problems may be viewed as risk factors for the severity and mortality of COVID-19. In addition, according to a February 2022 update by the National Institutes of Health, the panel advises testing hospitalized COVID-19 patients for thromboembolic disease if they experience a sudden localized loss of peripheral perfusion or a quick decline in pulmonary, cardiac, or neurological function. Therefore, it is anticipated that these studies will boost COVID-19 patients' need for coagulation analyzers, fueling the market's growth.
Further, the global coagulant analyzer market is driven by the increasing prevalence of chronic blood disorders, rising geriatric population coupled with the increasing prevalence of chronic diseases, and increasing laboratory automation. The increasing prevalence of chronic blood disorders is a major factor driving the market's growth. One of the key aspects influencing the market under study is the rising frequency of chronic blood disorders, which will increase the demand for coagulation analyzers. The Global Hemophilia Care 2020 study states that there have been 393,658 bleeding disorders recognized and documented globally over time, including 241,535 cases of hemophilia, and 87,729 cases of von Willebrand disease, and 64,394 cases of other bleeding disorders. As a result, the adoption of coagulation analyzers will be greatly boosted by the rising number of patients with blood disorders. In the United States, there were approximately 21,250 new instances of chronic lymphocytic leukemia in 2021, according to reports from the American Cancer Society (CLL). By examining blood cells that have been altered by leukemia, the illness is identified. Therefore, it is thought that the increasing number prevalence linked to chronic lymphocytic leukemia would increase the demand for coagulation tests, which will then propel market expansion. Product launches are another key factor in market growth. For instance, in July 2020, Automated Blood Coagulation Analyzers CN-6500/CN-3500, a novel product in the hemostasis sector, were introduced by Sysmex Corporation. With just one instrument, the new product may be used to measure all of the blood coagulation testing criteria, including molecular indicators for blood coagulation. Thus, the abovementioned factors are likely to increase market growth.
However, the high cost of fully automated coagulation analyzers and the slow adoption of advanced hemostasis instruments in developing and underdeveloped economies are restraining the market's growth.
Coagulation Analyzers Market Trends
This section covers the major market trends shaping the Coagulation Analyzers Market according to our research experts:
D-Dimer Testing Segment is Expected to Dominate the Market During the Forecast Period
Over the projected period, the D-dimer testing market is anticipated to have a considerable share in the studied market in the test type segment. One of the protein fragments created when a blood clot dissolves in the body is called D-dimer. Unless the body is creating or destroying blood clots, at which point its level in the blood might drastically rise, it is typically undetectable or only detectable at extremely low levels. Numerous studies show a connection between increased d-dimer and t-PA antigen levels and the risk of coronary heart disease (CHD). For instance, a study published in December 2020 called "D-dimers are associated with coronary artery disease severity assessed using Syntax and Syntax II scores in patients with ST-elevation myocardial infarction" found a correlation between elevated D-dimer levels and the severity of coronary artery disease (CAD).
The demand for D-Dimer analysis tools is anticipated to rise as fatalities from cancer, coronary heart disease, and cardiovascular disease are likely to rise. These instruments may aid in a better understanding of the diseases. As a result, these studies show that D-dimer testing is highly necessary, which increases the demand for coagulation analyzers. Additionally, a number of newer goods are being released, which is promoting the segment's growth. For instance, a medical device firm called Trivitron Healthcare introduced a new line of coagulation analyzer instruments made by Diagon Ltd. in October 2021. High-throughput specifications are offered by the product, including the crucial D-Dimer test for COVID-19. The segment is therefore anticipated to experience significant expansion throughout the forecast period as a result of the aforementioned factors.
North America is Expected to Dominate the Coagulation Analyzers Market
North America region is expected to hold a significant share in the market. The major factors fueling the market's growth are the increasing prevalence of chronic blood disorders, increasing laboratory automation, and the implementation of strategic initiatives by the market players. For instance, according to a February 2020 update by the Centers for Disease Control and Prevention (CDC), it is unknown how many people in the United States are affected by deep vein thrombosis, although that figure could reach 900,000 (1 to 2 per 1,000). Estimates from the same source state that 60,000-100,000 Americans perish from venous thromboembolism per year. In light of these figures, there is a greater requirement for early detection of blood abnormalities, which will increase the need for coagulation analyzers in the area and ultimately fuel market expansion. Additionally, a number of industry participants are implementing strategic plans, which is helping the market expand. For instance, the American company Haemonetics Corporation bought Enicor, the creator of a blood coagulation diagnostic system, in April 2020. Similar to this, the Stop Lab Cuts campaign was started by the American Clinical Laboratory Association (ACLA) in July 2022 with the goal of enhancing the clinical laboratory infrastructure to facilitate the provision of normal patient care. By revealing the necessary infrastructure and increasing funding in the nation, such efforts are likely to accelerate market expansion.Thus, due to the above-mentioned factors, the market is expected to witness significant growth over the forecast period.
Coagulation Analyzers Industry Overview
There has been a presence of a considerable number of companies that are significantly contributing to the market growth. Product innovation and ongoing R&D activities to develop advanced technologies has helped in boosting the growth of the market. The competition is fierce due to the consolidated nature of the market with top companies reporting to occupy major share in the market. The key players in the market are adopting various strategic moves to sustain the intense competition. Some of the major key players in the market include F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Helena Laboratories, Meril Life Sciences Pvt. Ltd. and Trivitron Healthcare, among others.
Coagulation Analyzers Market Leaders
-
F. Hoffmann-La Roche Ltd
-
Siemens Healthineers AG
-
Helena Laboratories
-
Meril Life Sciences Pvt. Ltd.
-
Trivitron Healthcare
*Disclaimer: Major Players sorted in no particular order
Coagulation Analyzers Market News
- In October 2021, Trivitron Healthcare, a medical devices company launched a new line of Coagulation Analyzer products in India manufactured by Diagon Ltd.
- In February 2021, Siemens Healthineers and Sysmex Corporation reported the renewal of the companies' long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis products including a multi-year extension. Additionally, the companies' agreement includes the future distribution of Sysmex's CN-Series automated blood coagulation analyzers, the CN-3000 and CN-6000, by Siemens Healthineers bringing the next generation of fully automated solutions for mid-and high-volume coagulation testing to laboratories.
Coagulation Analyzers Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Blood Disorders
4.2.2 Rising Geriatric Population Coupled with Increasing Prevalence of Chronic Diseases
4.2.3 Increasing Laboratory Automation
4.3 Market Restraints
4.3.1 Slow Adoption Rate in Underdeveloped Economies
4.3.2 High Cost of Test for Fully Automated Analyzers
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product
5.1.1 Analyzers
5.1.1.1 Clinical Laboratory Analyzers
5.1.1.2 Point of Care Analyzers
5.1.2 Consumables
5.2 By Test Type
5.2.1 Fibrinogen Testing
5.2.2 D-Dimer Testing
5.2.3 Platelet Function Tests
5.2.4 Other Coagulation Tests
5.3 By Technology
5.3.1 Optical Technology
5.3.2 Mechanical Technology
5.3.3 Electrochemical Technology
5.3.4 Others
5.4 By End User
5.4.1 Hospitals
5.4.2 Diagnostic Centers
5.4.3 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Beckman Coulter Inc.
6.1.3 Diagnostica Stago Sas
6.1.4 Eurolyser Diagnostica GmbH
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Helena Laboratories
6.1.7 Horiba
6.1.8 Meril Life Science Pvt. Ltd
6.1.9 Nihon Kohden Corporation
6.1.10 Siemens Healthcare
6.1.11 Thermo Fisher Scientific Inc
6.1.12 Trivitron Healthcare
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Coagulation Analyzers Industry Segmentation
As per the scope of this report, coagulation analyzers are used for detecting the presence of blood clots in the blood vessels. These analyzers measure coagulation pathway speed as well as thrombolin and thromboplastin levels in a few minutes. A coagulation analyzer system also has built-in quality control and security lockout protocols to ensure safe and secure use, as it is used on sensitive information about patients' health. The Coagulation Analyzers Market is segmented by Product (Analyzers (Clinical Laboratory Analyzers, and Point of Care Analyzers), and Consumables), By Test Type (Fibrinogen Testing, D-Dimer Testing, Platelet Function Tests and Other Coagulation Tests), Technology (Optical, Mechanical, Electrochemical, and Others), End-User (Hospitals, Diagnostic Centers and Others) and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product | ||||
| ||||
| Consumables |
| By Test Type | |
| Fibrinogen Testing | |
| D-Dimer Testing | |
| Platelet Function Tests | |
| Other Coagulation Tests |
| By Technology | |
| Optical Technology | |
| Mechanical Technology | |
| Electrochemical Technology | |
| Others |
| By End User | |
| Hospitals | |
| Diagnostic Centers | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Coagulation Analyzers Market Research FAQs
What is the current Global Coagulation Analyzers Market size?
The Global Coagulation Analyzers Market is projected to register a CAGR of 8.85% during the forecast period (2024-2029)
Who are the key players in Global Coagulation Analyzers Market?
F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Helena Laboratories, Meril Life Sciences Pvt. Ltd. and Trivitron Healthcare are the major companies operating in the Global Coagulation Analyzers Market.
Which is the fastest growing region in Global Coagulation Analyzers Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Coagulation Analyzers Market?
In 2024, the North America accounts for the largest market share in Global Coagulation Analyzers Market.
What years does this Global Coagulation Analyzers Market cover?
The report covers the Global Coagulation Analyzers Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Coagulation Analyzers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Coagulation Analyzers Industry Report
Statistics for the 2024 Coagulation Analyzers market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Coagulation Analyzers analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
